InvestorsHub Logo
Followers 18
Posts 910
Boards Moderated 0
Alias Born 01/07/2006

Re: north40000 post# 3893

Tuesday, 03/20/2018 12:47:09 PM

Tuesday, March 20, 2018 12:47:09 PM

Post# of 4124
Roth Capital raised its price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $6.00 (from $4.75) while maintaining a Buy rating following 4Q release. CPRX reported a 4Q EPS loss of $0.06, versus a targeted loss of $0.07. The company reached agreement with the FDA under a Special ...https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Catalyst+Pharmaceutical+Partners+%28CPRX%29+PT+Raised+to+%246+at+Roth+Capital+Following+4Q/13962031.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CPRX News